Results 191 to 200 of about 147,087 (295)
ABSTRACT Background Elinzanetant, a novel, dual neurokinin‐targeted therapy, has been approved in various geographies for the treatment of moderate‐to‐severe vasomotor symptoms (VMS) associated with menopause. Objective To compare the efficacy of elinzanetant with non‐hormonal pharmaceutical treatments (nHT) in alleviating VMS.
Piotr Wojciechowski +8 more
wiley +1 more source
A multicentre survey of Australian intensivists on optimal use of midazolam for sedation. [PDF]
Rawson J +3 more
europepmc +1 more source
Glucagon‐like peptide‐1 receptor agonist use and violent crime among US adults
Abstract Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), a class of medications widely prescribed for diabetes and obesity, have exhibited emerging effects on substance use, reward processing, and impulse control. This study examines whether current GLP‐1 RA use moderates established behavioral pathways to violent crime from impulsivity and ...
Daniel C. Semenza, Christopher Thomas
wiley +1 more source
Stress, stress systems, and Alzheimer's disease. [PDF]
Eberly SG +5 more
europepmc +1 more source
Based on metagenome‐assembled genomes (MAGs), the gut microbiota of the gray snub‐nosed monkeys recovered 1229 non‐redundant MAGs. The gut microbiota showed an enhanced capacity to produce energy substrates with increased conversion activity of these substrates during winter.
Yue Sun +17 more
wiley +1 more source
Effects of GS-967, GS-6615 and ranolazine on the responses of the rabbit aorta to adrenergic nerve stimulation. [PDF]
Mauricio MD +5 more
europepmc +1 more source
ABSTRACT Introduction Understanding the differences in treatment response between subtypes of major depressive disorder (MDD) may help to prevent lengthy trial‐and‐error processes by identifying effective treatment options. The aim of the study was to investigate the impact of atypical features of MDD (MDD‐A) on the response to lithium augmentation (LA)
Hannah Buchbauer +8 more
wiley +1 more source
Case Report: A possible novel adult-onset, progressive MAO-A hypofunction. [PDF]
Berteau S, Armitano E.
europepmc +1 more source

